Dr. Davis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11 Technology Dr
Irvine, CA 92618Phone+1 855-206-6764Fax+1 949-923-3575
Summary
- Dr. Barbara Davis is an internist in Mission Viejo, CA and is affiliated with multiple hospitals in the area, including Mission Hospital Mission Viejo, Saddleback Medical Center, and Children's Hospital of Orange County. She received her medical degree from Kansas City University of Medicine and Biosciences and has been in practice 13 years. She specializes in hospice & palliative medicine and hospital medicine/hospitalist.
Education & Training
- University of Arizona College of Medicine-PhoenixResidency, Internal Medicine, 2004 - 2007
- Kansas City University of Medicine and Biosciences College of Osteopathic MedicineClass of 2004
Certifications & Licensure
- CA State License 2007 - 2026
- AZ State License 2004 - 2006
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hospice and Palliative Medicine
Publications & Presentations
PubMed
- 457 citationsMechanisms of Phthalate Ester Toxicity in the Female Reproductive SystemTara Lovekamp-Swan, Barbara J. Davis
Environmental Health Perspectives. 2002-10-28 - 228 citationsGrowth of uterine leiomyomata among premenopausal black and white womenShyamal D. Peddada, Shannon K. Laughlin, Kelly Miner, Jean Philippe Guyon, Karen Haneke
Proceedings of the National Academy of Sciences of the United States of America. 2008-12-16 - 38 citationsIdentification of uterine leiomyoma genes developmentally reprogrammed by neonatal exposure to diethylstilbestrol.K.L. Greathouse, J.D. Cook, K. Lin, Barbara J. Davis, Tia D. Berry
Reproductive Sciences. 2008-05-14
Press Mentions
- COVID‐19 Pandemic and Diabetes CareApril 25th, 2022
- Primary Care and Diabetes Technologies and TreatmentsApril 25th, 2022
- RX-5902, a Novel Β-catenin Modulator, Potentiates the Efficacy of Immune Checkpoint Inhibitors in Preclinical Models of Triple-Negative Breast CancerNovember 4th, 2020
Grant Support
- Mechanistic Studies Of Female Reproductive ToxicantsNational Institute Of Environmental Health Sciences2003
- Mechanistic Studies Of Female Reproductive Toxicants AndNational Institute Of Environmental Health Sciences2001–2002
- Mechanistic Studies Of Female Reproductive Toxicants And CarcinogensNational Institute Of Environmental Health Sciences1999–2000
- Pathogenesis Of Ovarian ToxicantsNational Institute Of Environmental Health Sciences1994–1996
- Mechanistic Studies Of Ovarian ToxicityNational Institute Of Environmental Health Sciences1994–1995
- Pathogenesis Studies Of Ovarian ToxicantsNational Institute Of Environmental Health Sciences1992–1993
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: